Loading clinical trials...
Loading clinical trials...
A Preliminary Study of the Neurological and Neuropsychological Effects of Palynziq-Related Changes in Phenylalanine in Individuals With Phenylketonuria (PKU)
Conditions
Interventions
Pegvaliase-Pqpz
Locations
2
United States
Boston Children's Hospital
Boston, Massachusetts, United States
University of Missouri
Columbia, Missouri, United States
Start Date
May 25, 2022
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2025
Last Updated
December 29, 2025
NCT06560736
NCT06332807
NCT05051657
NCT03419819
NCT03856203
NCT04452513
Lead Sponsor
University of Missouri-Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions